"Betaxolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
| Descriptor ID |
D015784
|
| MeSH Number(s) |
D02.033.100.624.698.077 D02.033.755.624.698.077 D02.092.063.624.698.077
|
| Concept/Terms |
Betoptic- Betoptic
- Betoptima
- Betaxolol Alcon
- Alcon, Betaxolol
|
Below are MeSH descriptors whose meaning is more general than "Betaxolol".
Below are MeSH descriptors whose meaning is more specific than "Betaxolol".
This graph shows the total number of publications written about "Betaxolol" by people in this website by year, and whether "Betaxolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Betaxolol" by people in Profiles.
-
Carvalho AF, Van Bockstaele EJ. Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion. Neurosci Lett. 2011 Aug 1; 500(1):82-5.
-
Heijl A, Leske MC, Hyman L, Yang Z, Bengtsson B. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial. Acta Ophthalmol. 2011 Dec; 89(8):749-54.
-
Rudoy CA, Reyes AR, Van Bockstaele EJ. Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal. Neuropsychopharmacology. 2009 Apr; 34(5):1135-48.
-
Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007 Nov; 114(11):1965-72.
-
Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007 Feb; 114(2):205-9.
-
Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology. 2005 Sep; 112(9):1505-13.
-
Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol. 2004 Apr; 15(2):102-6.
-
Lin JC, Samuel F, Katz LJ, Spaeth GL, Hoop J, Cantor LB. The effect of topical glaucoma medications evaluated by perimetry. Br J Ophthalmol. 2003 Jun; 87(6):792.
-
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003 Jan; 121(1):48-56.
-
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct; 120(10):1268-79.